Loading...
XHKG
6833
Market cap53mUSD
Aug 08, Last price  
0.21HKD
1D
-10.04%
1Q
13.19%
Jan 2017
-62.55%
IPO
-72.89%
Name

Sinco Pharmaceuticals Holdings Ltd

Chart & Performance

D1W1MN
P/E
9.12
P/S
0.14
EPS
0.02
Div Yield, %
1.89%
Shrs. gr., 5y
3.74%
Rev. gr., 5y
19.12%
Revenues
2.82b
+11.07%
532,480,000950,079,0001,096,071,000858,894,000806,723,000952,957,0001,176,409,0002,049,803,0002,024,055,0002,271,505,0002,540,063,0002,821,321,000
Net income
42m
-0.72%
36,539,00069,367,00069,614,00019,367,000-185,896,000-280,614,00022,898,000118,137,000135,083,00069,462,00042,352,00042,045,000
CFO
-233m
L
77,899,00053,137,00046,196,000-29,903,000-358,654,000255,892,000-9,548,000137,300,000305,712,00075,081,000353,700,000-232,879,000
Dividend
May 20, 20240.0039 HKD/sh

Profile

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, such as the infections of the lower respiratory tract comprising pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. It also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases, including alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, a third generation oral cholic acid drug that is used for the treatment of gallstone diseases; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, the company engages in the sale of pharmaceutical products; and provides warehouse facilities for pharmaceutical products; and offers international trade services, as well as provides consultation services for medical and biological technology. The company was founded in 2011 and is headquartered in Chengdu, the People's Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.
URL
https://www.sinco-pharm.com/zh-cn/
IPO date
Mar 10, 2016
Employees
266
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,821,321
11.07%
2,540,063
11.82%
2,271,505
12.23%
Cost of revenue
2,729,378
2,427,649
2,174,508
Unusual Expense (Income)
NOPBT
91,943
112,414
96,997
NOPBT Margin
3.26%
4.43%
4.27%
Operating Taxes
56,875
57,529
29,830
Tax Rate
61.86%
51.18%
30.75%
NOPAT
35,068
54,885
67,167
Net income
42,045
-0.72%
42,352
-39.03%
69,462
-48.58%
Dividends
(18,112)
Dividend yield
3.71%
Proceeds from repurchase of equity
159,464
BB yield
-29.62%
Debt
Debt current
345,996
244,690
183,804
Long-term debt
14,171
16,369
11,606
Deferred revenue
(1,328)
Other long-term liabilities
1,351
23,878
(922)
Net debt
51,847
(176,863)
(528,109)
Cash flow
Cash from operating activities
(232,879)
353,700
75,081
CAPEX
(35,175)
(29,550)
(52,691)
Cash from investing activities
(52,870)
(63,626)
(119,270)
Cash from financing activities
154,587
(189,729)
35,043
FCF
(157,923)
55,615
52,101
Balance
Cash
308,320
437,922
329,144
Long term investments
394,375
Excess cash
167,254
310,919
609,944
Stockholders' equity
662,879
128,304
74,337
Invested Capital
847,513
775,027
731,748
ROIC
4.32%
7.29%
9.40%
ROCE
9.06%
12.44%
12.00%
EV
Common stock shares outstanding
2,032,891
2,032,891
2,031,576
Price
0.20
-17.92%
0.24
-9.43%
0.27
-85.98%
Market cap
400,479
-17.92%
487,894
-9.38%
538,368
-83.61%
EV
452,326
340,758
10,259
EBITDA
116,438
128,733
108,353
EV/EBITDA
3.88
2.65
0.09
Interest
9,808
13,813
Interest/NOPBT
8.72%
14.24%